Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
17 Feb 2015 FDA Approves Lenvatinib for Differentiated Thyroid Cancer Refractory to Iodine-131 Endocrine cancers - Anticancer agents & Biologic therapy
16 Feb 2015 Estimates of Gastric, Breast Cancer Risk in CDH1 Gene Mutation Carriers Breast cancer - Cancer in Special Situations - Gastrointestinal cancers
13 Feb 2015 ICHNO 2015 Press Release: New Research Shows Possibility of Cure for HPV Positive Throat Cancer Patients with Limited Distant Metastasis Head and neck cancers
13 Feb 2015 ICHNO 2015 Press Release: New Radiotracer Helps Avoid Neck Dissection in Patients with Early Head and Neck Cancer Head and neck cancers
12 Feb 2015 The International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model Could be Applied to Setting of Patients Previously Treated with Targeted Therapy Genitourinary cancers
11 Feb 2015 Common vs. Rare EGFR Mutations in Lung Adenocarcinoma Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
09 Feb 2015 Value of Innovation in Haematology Bioethics, legal and economic issues - Haematologic malignancies - Anticancer agents & Biologic therapy
06 Feb 2015 European Medicines Agency Recommends a Variation to the Terms of the Marketing Authorisation for Palonosetron Palliative and supportive care - Anticancer agents & Biologic therapy
05 Feb 2015 FDA Approves Palbociclib for Postmenopausal Women With Advanced Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
04 Feb 2015 ESMO Press Release: Making Equal Access to Cancer Treatment A Priority
03 Feb 2015 Large Study Catalogues Genetic Alterations in Head and Neck Squamous Cell Carcinomas Translational research - Head and neck cancers
02 Feb 2015 FDA Expands Approved Use of Ibrutinib to Waldenström’s Macroglobulinaemia Haematologic malignancies - Anticancer agents & Biologic therapy
30 Jan 2015 First Major Analysis of Human Protein Atlas Translational research
29 Jan 2015 European Medicines Agency Recommends a Variation to the Terms of the Marketing Authorisation for Ruxolitinib Haematologic malignancies - Anticancer agents & Biologic therapy
28 Jan 2015 Withdrawal of the Application for a Change to the Marketing Authorisation for Tegafur/Gimeracil/Oteracil Gastrointestinal cancers - Anticancer agents & Biologic therapy